FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vasilios Athyros

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Geographic Areas

Greece

Procedures

Drug Therapy, Combination

Co-author Network

Publications

TOP 3
Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Hyperuricaemia: more than just a cause of gout?
Panagiotis Anagnostis; Vasilios G Athyros; Marina Kita; Asterios Karagiannis
Is there any association between adiponectin gene polymorphisms and cardiovascular disease?
Vasilios G Athyros; Niki Katsiki; Asterios Karagiannis
Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vasilios Athyros (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Hyperuricaemia: more than just a cause of gout?
Journal of cardiovascular medicine (Hagerstown, Md.) 2013;14(6):397-402.
2013: Panagiotis Anagnostis; Vasilios G Athyros; Marina Kita; Asterios Karagiannis
Is there any association between adiponectin gene polymorphisms and cardiovascular disease?
Angiology 2013;64(4):253-6.
2013: Vasilios G Athyros; Niki Katsiki; Asterios Karagiannis
Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention.
Circulation journal : official journal of the Japanese Circulation Society 2013;77(5):1348.
2013: Michael S Kostapanos; Dimitri P Mikhailidis; Vasilios G Athyros; Moses S Elisaf
Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity.
Journal of clinical lipidology 2013;7(1):88.
2013: Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis; Vasilios G Athyros
Colesevelam: a new and improved bile Acid sequestrant?
Current pharmaceutical design 2013;19(17):3115-23.
2013: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Eleni Theocharidou; Dimitri P Mikhailidis
Ezetimibe therapy for dyslipidemia: an update.
Current pharmaceutical design 2013;19(17):3107-14.
2013: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property".
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2013;45(1):82-3.
2013: Panagiotis Anagnostis; Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Marina Kita; Fotini Adamidou; Dimitri P Mikhailidis
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
Metabolism: clinical and experimental 2013;62(1):21-33.
2012: Niki Katsiki; Dimitri P Mikhailidis; Vasilios G Athyros; Asterios Karagiannis
Editorial: aliskiren/amlodipine single-pill combinations: more evidence in favour of combination formulations for the treatment of hypertension.
Current vascular pharmacology 2012;10(6):745-7.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity.
The American journal of cardiology 2012;110(5):763.
2012: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Smoking and non-alcoholic steatohepatitis (NASH): the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial.
Journal of hepatology 2012;57(2):476.
2012: Charalambos Koumaras; Dimitri P Mikhailidis; Eirini Stavrinou; Maria Tzimou; Vasilios G Athyros; Thomas D Gossios; Theodora Griva; Niki Katsiki; Asterios Karagiannis
Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2012;12(3):143-56.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Statins in patients with renal dysfunction.
The American journal of cardiology 2012;109(10):1537.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Editorial: should chronic kidney disease be considered as a coronary heart disease equivalent?
Current vascular pharmacology 2012;10(3):374-7.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Response to 'Mildly decreased glomerular filtration rate is associated with poor coronary heart disease outcome'.
Clinical cardiology 2012;35(5):315; author reply 316-7.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Should raising high-density lipoprotein cholesterol be a matter of debate?
Journal of cardiovascular medicine (Hagerstown, Md.) 2012;13(4):254-9.
2012: Michael S Kostapanos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
Digestive diseases and sciences 2012;57(4):1109.
2012: Michael S Kostapano; Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Effects of Losartan vs. Enalapril on the Markers of Metabolic Syndrome.
Oman medical journal 2012;27(2):177.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Stage of chronic kidney disease and severity of coronary heart disease manifestation.
Expert opinion on pharmacotherapy 2012;13(4):457-60.
2012: Michael S Kostapanos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Therapeutic options for statin-intolerant patients.
Current medical research and opinion 2012;28(3):345-9.
2012: Vasilios G Athyros; Thomas D Gossios; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings.
Archives of medical science : AMS 2012;8(1):6-10.
2012: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome.
Expert opinion on pharmacotherapy 2012;13(2):287-8; author reply 289-90.
2012: Vasilios G Athyros; Dimitri P Mikhailidis
Patient with hypertriglyceridemia, type 2 diabetes, and chronic kidney disease treated with atorvastatin and omega-3 Fatty Acid ethyl esters.
The open cardiovascular medicine journal 2012;6():122-5.
2012: Eydoxia K Mitsiou; Vasilios G Athyros; Asterios Karagiannis; Dimitri I Mikhailidis
Is there a role for hypolipidaemic drug therapy in the prevention or treatment of microvascular complications of diabetes?
The open cardiovascular medicine journal 2012;6():28-32.
2012: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Fibrinogen, hematocrit, and platelets in mild kidney dysfunction and the role of uric acid: an Italian male population study.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012;18(1):113-4.
2012: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.
Journal of clinical lipidology 2012;6(1):93.
2012: Niki Katsiki; Charalambos Koumaras; Vasilios G Athyros; Asterios Karagiannis
Thinking beyond traditional cardiovascular risk factors: the role of arterial stiffness in targeting residual risk.
Angiology 2012;63(1):9-11.
2012: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Lipid lowering agents and the endothelium: an update after 4 years.
Current vascular pharmacology 2012;10(1):33-41.
2011: Vasilios G Athyros; Matilda Florentin; Thomas D Gossios; Asterios Karagiannis; Konstantinos Tziomalos; Dimitri P Mikhailidis
Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
Archives of medical science : AMS 2011;7(6):1067-75.
2011: Vasilios G Athyros; Thomas D Gossios; Apostolos I Hatzitolios; Anna Kakafika; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis; Aikaterini Papagianni; Christos Savopoulos; Konstantinos Tziomalos
IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis.
Archives of medical science : AMS 2011;7(6):984-92.
2011: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?
Current vascular pharmacology 2011;9(6):698-705.
2011: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Current treatment for nonalcoholic fatty liver disease.
Expert opinion on pharmacotherapy 2011;12(13):2141-2; author reply 2142.
2011: N Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Vitamin D deficiency, statin-related myopathy and other links with vascular risk.
Current medical research and opinion 2011;27(9):1691-2.
2011: Niki Katsiki; Vasilios G Athyros; Dimitri P Mikhailidis
Does metabolic syndrome influence outcome following percutaneous coronary intervention?
Angiology 2011;62(6):437-9.
2011: Vasilios G Athyros; Asterios Karagiannis; Konstantinos Tziomalos; Dimitri P Mikhailidis
Cardiovascular benefits of bariatric surgery in morbidly obese patients.
Obesity reviews : an official journal of the International Association for the Study of Obesity 2011;12(7):515-24.
2011: Eirini Stavrinou; Konstantinos Tziomalos; Vasilios G Athyros; Thomas D Gossios; Charalambos Koumaras; Asterios Karagiannis
Atherosclerotic renal artery stenosis: an update on diagnosis and management.
Current vascular pharmacology 2011;9(4):465-70.
2011: Panagiotis Anagnostis; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Impact of statins on glucose metabolism--a matter of debate.
The American journal of cardiology 2011;107(12):1866.
2011: P Anagnostis; D Selalmatzidou; S A Polyzos; A Panagiotou; A Slavakis; A Panagiotidou; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis; M Kita
Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study.
International journal of clinical practice 2011;65(6):679-83.
2011: Efstathios D Pagourelias; Thomas D Gossios; Konstantinos Tziomalos; Asterios Karagiannis; Paraschos Geleris; Vasilios G Athyros
Residual cardiac risk reduction beyond lipid lowering.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2011;52(3):197-203.
2011: Vasilios G Athyros; Konstantinos Tziomalos; Georgios N Daskalopoulos; Asterios Karagiannis; Dimitri P Mikhailidis
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
Annals of medicine 2011;43(3):167-71.
2011: Georgios N Daskalopoulos; Artemis Karkanaki; Asterios Karagiannis; Dimitri P Mikhailidis; Vasilios G Athyros
Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?
Angiology 2011;62(4):285-90.
2011: P Anagnostis; Vasilios G Athyros; F Adamidou; A Panagiotou; M Kita; Asterios Karagiannis; Dimitri P Mikhailidis
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.
Diabetes, obesity & metabolism 2011;13(4):302-12.
2011: Panagiotis Anagnostis; Vasilios G Athyros; Themistoklis Vasiliadis; Theodora Griva; Kalliopi Patsiaoura; Asterios Karagiannis
Should we consider Addison's disease in the differential diagnosis of persistent hypertransaminasemia? A case report.
Acta gastro-enterologica Belgica 2011;74(1):95-6.
2011: Niki Katsiki; Vasilios G Athyros; Dimitri P Mikhailidis
The DEFINE study: a bright future for CETP inhibitors?
Expert opinion on investigational drugs 2011;20(3):311-4.
2011: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases.
The open cardiovascular medicine journal 2011;5():85-9.
2011: Niki Katsiki; Dimitri P Mikhailidis; Vasilios G Athyros; Asterios Karagiannis
Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance.
Circulation journal : official journal of the Japanese Circulation Society 2011;75(8):2027; author reply 2028.
2011: Vasilios G Athyros; Asterios Karagiannis; Konstantinos Tziomalos; Dimitri P Mikhailidis
Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment.
The open cardiovascular medicine journal 2011;5():24-34.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Thomas D Gossios; Theodora Griva; Panagiotis Anagnostis; Konstantinos Kargiotis; Efstathios D Pagourelias; Eleni Theocharidou; Asterios Karagiannis; Dimitri P Mikhailidis
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.
Lancet 2010;376(9756):1916-22.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
To switch (statins) or not to switch? That is the question.
Expert opinion on pharmacotherapy 2010;11(18):2943-6.
2010: Asterios Karagiannis; Konstantinos Tziomalos; Panagiotis Anagnostis; Thomas D Gossios; Matilda Florentin; Vasilios G Athyros; Dimitri P Mikhailidis
The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis.
Current vascular pharmacology 2010;8(6):792-803.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Statin-fibrate combination for mixed dyslipidaemia: a limited option?
Current medical research and opinion 2010;26(9):2137-40.
2010: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Management of statin-intolerant high-risk patients.
Current vascular pharmacology 2010;8(5):632-7.
2010: Panagiotis Anagnostis; Asterios Karagiannis; Konstantinos Tziomalos; Vasilios G Athyros; Marina Kita; Dimitri P Mikhailidis
Endocrine hypertension: diagnosis and management of a complex clinical entity.
Current vascular pharmacology 2010;8(5):646-60.
2010: Panagiotis Anagnostis; Vasilios G Athyros; Fotini Adamidou; Matilda Florentin; Asterios Karagiannis
Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?
Current vascular pharmacology 2010;8(5):720-30.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Lipid-lowering agents and new onset diabetes mellitus.
Expert opinion on pharmacotherapy 2010;11(12):1965-70.
2010: Efstratios Moralidis; T Didangelos; Georgios Arsos; Vasilios G Athyros; Dimitri P Mikhailidis
Myocardial perfusion scintigraphy in asymptomatic diabetic patients: a critical review.
Diabetes/metabolism research and reviews 2010;26(5):336-47.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Atorvastatin: safety and tolerability.
Expert opinion on drug safety 2010;9(4):667-74.
2010: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification.
Current opinion in cardiology 2010;25(4):394-8.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Anthony S Wierzbicki; Dimitri P Mikhailidis
Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?
Current opinion in cardiology 2010;25(4):406-10.
2010: Asterios Karagiannis; Konstantinos Tziomalos; Efstathios D Pagourelias; Thomas D Gossios; Vasilios G Athyros
Effect of antihypertensive drug-associated diabetes on cardiovascular risk.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2010;51(3):195-9.
2010: Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Statins and heart failure.
Journal of the American College of Cardiology 2010;55(15):1644-5; author reply 1646.
2010: Vasilios G Athyros; Eydoxia K Mitsiou; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy.
Expert opinion on pharmacotherapy 2010;11(5):723-30.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Matilda Florentin; Asterios Karagiannis; Dimitri P Mikhailidis
Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?
Current medical research and opinion 2010;26(4):839-42.
2010: E D Pagourelias; G Giannoglou; Evangelia Kouidi; Georgios K Efthimiadis; P Zorou; K Tziomalos; Asterios Karagiannis; Vasilios G Athyros; P Geleris; Dimitri P Mikhailidis
Brain natriuretic peptide and the athlete's heart: a pilot study.
International journal of clinical practice 2010;64(4):511-7.
2010: Vasilios G Athyros; Emmanuel S Ganotakis; Konstantinos Tziomalos; Athanasios A Papageorgiou; Panagiotis Anagnostis; Theodora Griva; Konstantinos Kargiotis; Eydoxia K Mitsiou; Asterios Karagiannis; Dimitri P Mikhailidis
Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
Current medical research and opinion 2010;26(3):713-9.
2010: Theodoros Chimonas; Vasilios G Athyros; Emmanuel S Ganotakis; Vassilios Nicolaou; Demosthenes B Panagiotakos; Dimitri P Mikhailidis; Moses Elisaf
Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome.
Angiology 2010;61(1):49-57.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?
Current pharmaceutical design 2010;16(34):3939-847.
2010: N Katsiki; Vasilios G Athyros; Dimitri P Mikhailidis
New developments in the treatment and prevention of vascular disease--part 1.
Current pharmaceutical design 2010;16(34):3767-9.
2010: Vasilios G Athyros; Eydoxia K Mitsiou; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective?
Current vascular pharmacology 2010;8(1):1-4.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Panagiotis Anagnostis; Dimitri P Mikhailidis
Should adipokines be considered in the choice of the treatment of obesity-related health problems?
Current drug targets 2010;11(1):122-35.
2009: Eydoxia K Mitsiou; Konstantinos Tziomalos; Panagiotis Anagnostis; Asterios Karagiannis; Vasilios G Athyros
Multifactorial intervention for the prevention of vascular complications of type 2 diabetes.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2009;50(6):445-8.
2009: Vasilios G Athyros; A Hatzitolios; Asterios Karagiannis; Triandafillos P Didangelos; F Iliadis; S Dolgyras; T Vosnakidis; P Vasiliadis; I Malias; Konstantinos Tziomalos; M Samouilidou; Dimitri P Mikhailidis
Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study.
Current medical research and opinion 2009;25(8):1931-40.
2009: Asterios Karagiannis; Konstantinos Tziomalos; Panagiotis Anagnostis; Thomas Gossios; Vasilios G Athyros
Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?
Angiology 2009;60(4):397-402.
2009: Panagiotis Anagnostis; Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.
The Journal of clinical endocrinology and metabolism 2009;94(8):2692-701.
2009: Panagiotis Anagnostis; Asterios Karagiannis; Konstantinos Tziomalos; Anna I Kakafika; Vasilios G Athyros; Dimitri P Mikhailidis
Adrenal incidentaloma: a diagnostic challenge.
Hormones (Athens, Greece) 2009;8(3):163-84.
2009: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention.
Current vascular pharmacology 2009;7(3):264-6.
2009: Konstantinos Tziomalos; Vasilios G Athyros; Anthony S Wierzbicki; Dimitri P Mikhailidis
Lipoprotein a: where are we now?
Current opinion in cardiology 2009;24(4):351-7.
2009: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Genovefa D Kolovou; Dimitri P Mikhailidis
Triglycerides and vascular risk: insights from epidemiological data and interventional studies.
Current drug targets 2009;10(4):320-7.
2009: Asterios Karagiannis; Vasilios G Athyros; Dimitri P Mikhailidis
A comparison of the aldosterone-blocking agents eplerenone and spironolactone.
Clinical cardiology 2009;32(4):230.
2009: Vasilios G Athyros; Asterios Karagiannis; A I Hatzitolios; K Paletas; C Savopoulos; G Giannoglou; Dimitri P Mikhailidis
Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study.
Current medical research and opinion 2009;25(4):971-80.
2009: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
The JUPITER trial results boost the evidence for the use of hsCRP as a treatment target and as part of the assessment of vascular risk: time for new guidelines?
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2009;50(2):89-91.
2009: Efstathios D Pagourelias; Charalambos Koumaras; Anna I Kakafika; Konstantinos Tziomalos; Paraskevi G Zorou; Vasilios G Athyros; Asterios Karagiannis
Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
Angiology 2009;60(1):74-81.
2009: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Dyslipidemia as a risk factor for ischemic stroke.
Current topics in medicinal chemistry 2009;9(14):1291-7.
2009: Asterios Karagiannis; Apostolos Hatzitolios; Vasilios G Athyros; Kalliopi Deligianni; Charalambos Charalambous; Christos Papathanakis; Georgios Theodosiou; Theodoros Drakidis; Veronika Chatzikaloudi; Chysanthi Kamilali; Sotirios Matsiras; Athanasios Matziris; Christos Savopoulos; Maria Baltatzi; Jobst Rudolf; Konstantinos Tziomalos; Dimitri P Mikhailidis
Implementation of guidelines for the management of arterial hypertension. The impulsion study.
The open cardiovascular medicine journal 2009;3():26-34.
2009: Konstantinos Tziomalos; Anna I Kakafika; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
The role of statins for the primary and secondary prevention of coronary heart disease in women.
Current pharmaceutical design 2009;15(10):1054-62.
2009: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
JUPITER: major implications for vascular risk assessment.
Current medical research and opinion 2009;25(1):133-7.
2009: Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Pleiotropic effects of statins--clinical evidence.
Current pharmaceutical design 2009;15(5):479-89.
2009: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Anti-inflammatory effects of fibrates: an overview.
Current medicinal chemistry 2009;16(6):676-84.
2009: Vasilios G Athyros; Anna I Kakafika; Anthony S Wierzbicki; Asterios Karagiannis; Dimitri P Mikhailidis
Targeting triglycerides in secondary prevention: should we bother?
International journal of clinical practice 2009;63(1):15-8.
2008: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Preventing macrovascular complications of diabetes: where do we stand with glycemic control?
Expert opinion on investigational drugs 2008;17(12):1777-9.
2008: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Omega-3 fatty acids: how can they be used in secondary prevention?
Current atherosclerosis reports 2008;10(6):510-7.
2008: Konstantinos Tziomalos; Vasilios G Athyros; Dimitri P Mikhailidis
Statin discontinuation: an underestimated risk?
Current medical research and opinion 2008;24(11):3059-62.
2008: Asterios Karagiannis; Konstantinos Tziomalos; Anna I Kakafika; Vasilios G Athyros; Faidon Harsoulis; Dimitri P Mikhailidis
Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
Endocrine-related cancer 2008;15(3):693-700.
2008: Vasilios G Athyros; Anna I Kakafika; Asterios Karagiannis; Dimitri P Mikhailidis
Do we need to consider inflammatory markers when we treat atherosclerotic disease?
Atherosclerosis 2008;200(1):1-12.
2008: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?
Expert opinion on therapeutic targets 2008;12(7):809-20.
2008: Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?
Expert opinion on investigational drugs 2008;17(7):969-72.
2008: Anna I Kakafika; Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?
Expert opinion on pharmacotherapy 2008;9(9):1437-40.
2008: Vasilios G Athyros; Anna I Kakafika; Asterios Karagiannis; Asterios Koragiannis; Dimitri P Mikhailidis; Dimitri P Mikhalidis
Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.
The American journal of cardiology 2008;101(11):1679-80.
2008: Vasilios G Athyros; Anna I Kakafika; Athanasios A Papageorgiou; Kosmas I Paraskevas; Konstantinos Tziomalos; Panagiotis Anagnostis; Efstathios Pagourelias; Charalambos Koumaras; Asterios Karagiannis; Dimitri P Mikhailidis
Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.
Current medical research and opinion 2008;24(6):1593-9.
2008: Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Athanassios A Papageorgiou; Asterios Karagiannis
Statins for the prevention of first or recurrent stroke.
Current vascular pharmacology 2008;6(2):124-33.
2008: Georgios Efstratiadis; Konstantinos Tziomalos; Dimitri P Mikhailidis; Vasilios G Athyros; Apostolos Hatzitolios
Atherogenesis in renal patients: a model of vascular disease?
Current vascular pharmacology 2008;6(2):93-107.
2008: Asterios Karagiannis; Dimitri P Mikhailidis; Konstantinos Tziomalos; Anna I Kakafika; Vasilios G Athyros
Has the time come for a new definition of microalbuminuria?
Current vascular pharmacology 2008;6(2):81-3.
2008: Vasilios G Athyros; Anna Kakafika; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?
Expert opinion on investigational drugs 2008;17(4):445-9.
2008: Asterios Karagiannis; Konstantinos Tziomalos; Athanasios Papageorgiou; Anna I Kakafika; Efstathios D Pagourelias; Panagiotis Anagnostis; Vasilios G Athyros; Dimitri P Mikhailidis
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
Expert opinion on pharmacotherapy 2008;9(4):509-15.
2008: Vasilios G Athyros; Konstantinos Tziomalos; Anna I Kakafika; Haralambos Koumaras; Asterios Karagiannis; Dimitri P Mikhailidis
Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
The American journal of cardiology 2008;101(4):483-5.
2008: Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
CORONA, statins, and heart failure: who lost the crown?
Angiology 2008;59(1):5-8.
2008: Anna I Kakafika; Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
High density lipoprotein cholesterol and statin trials.
Current medicinal chemistry 2008;15(22):2265-70.
2008: Panagiotis Anagnostis; Maria Stangou; Maria Leontsini; Vasilios G Athyros; Asterios Karagiannis
Unusual manifestation of diarrhea-associated haemolytic uraemic syndrome in an adult.
Renal failure 2008;30(3):331-4.
2007: Vasilios G Athyros; Evagelos N Liberopoulos; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Emmanuel S Ganotakis; Konstantinos Tziomalos; Anna I Kakafika; Asterios Karagiannis; Stylianos Lambropoulos; Moses Elisaf
Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
Angiology 2007;58(6):689-97.
2007: Asterios Karagiannis; Dimitri P Mikhailidis; Vasilios G Athyros; Faidon Harsoulis
Pheochromocytoma: an update on genetics and management.
Endocrine-related cancer 2007;14(4):935-56.
2007: Vasilios G Athyros; Anna I Kakafika; Athanasios A Papageorgiou; Konstantinos Tziomalos; Athanasios Skaperdas; Efstathios Pagourelias; Athina Pirpasopoulou; Asterios Karagiannis; Dimitri P Mikhailidis
Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients.
Lipids 2007;42(11):999-1009.
2007: Vasilios G Athyros; Konstantinos Tziomalos; Dimitri P Mikhailidis; Efstathios D Pagourelias; Anna I Kakafika; Athanasios Skaperdas; Apostolos Hatzitolios; Asterios Karagiannis
Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?
Expert opinion on pharmacotherapy 2007;8(14):2267-77.
2007: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Endothelial function, arterial stiffness and lipid lowering drugs.
Expert opinion on therapeutic targets 2007;11(9):1143-60.
2007: Kosmas I Paraskevas; Vasilios G Athyros; Despina D Briana; Anna I Kakafika; Asterios Karagiannis; Dimitri P Mikhailidis
Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures.
Current drug targets 2007;8(8):942-51.
2007: Theodosios D Filippatos; Irene Gazi; Evagelos N Liberopoulos; Vasilios G Athyros; Moses S Elisaf; Alexandros D Tselepis; Dimitrios N Kiortsis
The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome.
Atherosclerosis 2007;193(2):428-37.
2007: Anna I Kakafika; Dimitri P Mikhailidis; Anthony S Wierzbicki; Asterios Karagiannis; Vasilios G Athyros
PCI and stable coronary heart disease--COURAGE to change our minds?
Current vascular pharmacology 2007;5(3):173-4.
2007: Asterios Karagiannis; Dimitri P Mikhailidis; Konstantinos Tziomalos; Maria Sileli; Savvas Savvatianos; Anna I Kakafika; Thomas Gossios; Napoleon Krikis; Irene Moschou; Michael Xochellis; Vasilios G Athyros
Serum uric acid as an independent predictor of early death after acute stroke.
Circulation journal : official journal of the Japanese Circulation Society 2007;71(7):1120-7.
2007: Vasilios G Athyros; Anna I Kakafika; Asterios Karagiannis; Dimitri P Mikhailidis
Statins and regression of coronary atherosclerosis.
JAMA : the journal of the American Medical Association 2007;297(20):2197; author reply 2197.
2007: Asterios Karagiannis; Konstantinos Tziomalos; Vasilios G Athyros
Is angioedema a class adverse effect of the angiotensin-converting enzyme inhibitors?
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2007;98(5):502.
2007: Anna I Kakafika; Dimitri P Mikhailidis; Asterios Karagiannis; Vasilios G Athyros
The role of endocannabinoid system blockade in the treatment of the metabolic syndrome.
Journal of clinical pharmacology 2007;47(5):642-52.
2007: Vasilios G Athyros; Emmanuel S Ganotakis; Moses S Elisaf; Evagelos N Liberopoulos; Ioannis A Goudevenos; Asterios Karagiannis
Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
International journal of cardiology 2007;117(2):204-10.
2007: Vasilios G Athyros; Dimitri P Mikhailidis; Anna I Kakafika; Konstantinos Tziomalos; Asterios Karagiannis
Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
Expert opinion on pharmacotherapy 2007;8(5):529-35.
2007: Vasilios G Athyros; Dimitri P Mikhailidis; Anna I Kakafika; Asterios Karagiannis; Apostolos Hatzitolios; Konstantinos Tziomalos; Emmanuel S Ganotakis; Evagelos N Liberopoulos; Moses Elisaf
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.
Current drug targets 2007;8(3):483-8.
2007: Vasilios G Athyros; Asterios Karagiannis; Anna I Kakafika; Moses Elisaf; Dimitri P Mikhailidis
Statins and renal function. Is the compound and dose making a difference?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(3):963-4; author reply 964.
2007: Asterios Karagiannis; Dimitri P Mikhailidis; Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Evagelos N Liberopoulos; Matilda Florentin; Moses Elisaf
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?
Expert opinion on therapeutic targets 2007;11(2):191-205.
2007: Vasilios G Athyros; Anna I Kakafika; Athanasios A Papageorgiou; Efstathios D Pagourelias; Savvas D Savvatianos; Moses Elisaf; Asterios Karagiannis; Konstantinos Tziomalos; Dimitri P Mikhailidis
Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.
The open cardiovascular medicine journal 2007;1():8-14.
2007: Asterios Karagiannis; Dimitri P Mikhailidis; Anna I Kakafika; Konstantinos Tziomalos; Vasilios G Athyros
Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?
Current pharmaceutical design 2007;13(2):229-39.
2007: Asterios Karagiannis; Konstantinos Tziomalos; Anna I Kakafika; Matilda Florentin; Vasilios G Athyros
Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(1):293.
2007: Vasilios G Athyros; Dimitri P Mikhailidis; Evagelos N Liberopoulos; Anna I Kakafika; Asterios Karagiannis; Athanasios A Papageorgiou; Konstantinos Tziomalos; Emmanuel S Ganotakis; Moses Elisaf
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(1):118-27.
2006: Asterios Karagiannis; Lemonia Mathiopoulou; Konstantinos Tziomalos; Konstantinos Kontotasios; Athanasios Skaperdas; Matilda Florentin; Ioannis K Amplianitis; Vasilios G Athyros
Dry cough as first manifestation of giant-cell arteritis.
Journal of the American Geriatrics Society 2006;54(12):1957-8.
2006: Sofia G Tsouli; Evagelos N Liberopoulos; Dimitri P Mikhailidis; Vasilios G Athyros; Moses S Elisaf
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
Metabolism: clinical and experimental 2006;55(10):1293-301.
2006: Asterios Karagiannis; Vasilios G Athyros; Athanasios Papageorgiou; Konstantinos Tziomalos; Moses Elisaf
Should atenolol still be recommended as first-line therapy for primary hypertension?
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2006;47(5):298-307.
2006: Stella S Daskalopoulou; Vasilios G Athyros; Genovefa D Kolovou; Katherine K Anagnostopoulou; Dimitri P Mikhailidis
Definitions of metabolic syndrome: Where are we now?
Current vascular pharmacology 2006;4(3):185-97.
2006: Anna I Kakafika; Evagelos N Liberopoulos; Asterios Karagiannis; Vasilios G Athyros; Dimitri P Mikhailidis
Dyslipidaemia, hypercoagulability and the metabolic syndrome.
Current vascular pharmacology 2006;4(3):175-83.
2006: Vasilios G Athyros; Dimitri P Mikhailidis; Triandafillos P Didangelos; Olga Giouleme; Evagelos N Liberopoulos; Asterios Karagiannis; Anna I Kakafika; Konstantinos Tziomalos; Andrew K Burroughs; Moses S Elisaf
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.
Current medical research and opinion 2006;22(5):873-83.
2006: Georgios Efstratiadis; Georgios Tsiaousis; Vasilios G Athyros; Despina Karagianni; Aikaterini Pavlitou-Tsiontsi; Anastasia Giannakou-Darda; Christos Manes
Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes.
Angiology 2006;57(3):303-11.
2006: Asterios Karagiannis; Athina Pyrpasopoulou; Konstantinos Tziomalos; Matilda Florentin; Vasilios G Athyros
Angioedema may not be a class side-effect of the angiotensin-converting-enzyme inhibitors.
QJM : monthly journal of the Association of Physicians 2006;99(3):197-8.
2006: Evagelos N Liberopoulos; Dimitri P Mikhailidis; Vasilios G Athyros; Moses S Elisaf
The effect of cholesterol-lowering treatment on renal function.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;47(3):561; author reply 562.
2006: Konstantinos Tziomalos; Vasilios G Athyros
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review.
International journal of nanomedicine 2006;1(2):129-47.
2006: Irene Gazi; Evagelos N Liberopoulos; Vasilios G Athyros; Moses Elisaf; Dimitri P Mikhailidis
Statins and solid organ transplantation.
Current pharmaceutical design 2006;12(36):4771-83.
2006: Triandafillos P Didangelos; Georgios A Arsos; Dimitrios T Karamitsos; Vasilios G Athyros; Stamatia D Georga; Nikolaos D Karatzas
Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy.
Journal of diabetes and its complications 2006;20(1):1-7.
2005: Asterios Karagiannis; Konstantinos Tziomalos; Konstantina Dona; Athina Pyrpasopoulou; Nikoleta Kartali; Vasilios G Athyros; Chrysanthos Zamboulis
Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient.
QJM : monthly journal of the Association of Physicians 2005;98(12):913-5.
2005: Vasilios G Athyros; Emmanuel S Ganotakis; Maria Bathianaki; Ioannis Monedas; Ioannis A Goudevenos; Athanasios A Papageorgiou; Athanasios Papathanasiou; Anna I Kakafika; Dimitri P Mikhailidis; Moses Elisaf
Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2005;46(6):380-6.
2005: E J Diamantopoulos; Vasilios G Athyros; GK Yfanti; E N Migdalis; M Elisaf; P E Vardas; A S Manolis; Dimitrios T Karamitsos; E S Ganotakis; D Hatseras
The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study.
Angiology 2005;56(6):731-41.
2005: Vasilios G Athyros; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Triandafillos P Didangelos; Athanasia Peletidou; Drosia Kleta; Asterios Karagiannis; Anna I Kakafika; Konstantinos Tziomalos; Moses Elisaf
Targeting vascular risk in patients with metabolic syndrome but without diabetes.
Metabolism: clinical and experimental 2005;54(8):1065-74.
2005: Vasilios G Athyros; Emmanuel S Ganotakis; Moses Elisaf; Dimitri P Mikhailidis
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions.
Current medical research and opinion 2005;21(8):1157-9.
2005: Vasilios G Athyros; Vasilios I Bouloukos; Anthimos N Pehlivanidis; Athanasios A Papageorgiou; S G Dionysopoulou; Athanasios N Symeonidis; D I Petridis; M I Kapousouzi; E A Satsoglou; Dimitri P Mikhailidis
The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.
Diabetes, obesity & metabolism 2005;7(4):397-405.
2005: Stella S Daskalopoulou; Vasilios G Athyros; George Hamilton; Dimitri P Mikhailidis
Lipid-lowering therapy in patients with peripheral arterial disease.
Journal of cardiovascular pharmacology and therapeutics 2005;10(2):145-7.
2005: Evagelos N Liberopoulos; Vasilios G Athyros; Moses S Elisaf; Dimitri P Mikhailidis
New-onset diabetes after transplantation.
Lancet 2005;365(9473):1766.
2005: Evagelos N Liberopoulos; Vasilios G Athyros; Moses S Elisaf; Dimitri P Mikhailidis
Targets for low-density lipoprotein cholesterol levels in patients with stable coronary heart disease: where are we now after the "treating to new targets" (TNT) trial?
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2005;46(3):161-4.
2005: Evagelos N Liberopoulos; George Miltiadous; Vasilios G Athyros; Manolis Ganotakis; Marios A Cariolou; Eleni Bairaktari; Moses S Elisaf
Effect of apolipoprotein E polymorphism on serum uric acid levels in healthy subjects.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2005;53(3):116-22.
2005: Vasilios G Athyros; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Vasilios I Bouloukos; Anthimos N Pehlivanidis; Athanasios N Symeonidis; Anna I Kakafika; Stella S Daskalopoulou; Moses Elisaf
Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study.
Platelets 2005;16(2):65-71.
2004: Vasilios G Athyros; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Triandafillos P Didangelos; Emmanuel S Ganotakis; Athanasios N Symeonidis; Stella S Daskalopoulou; Anna I Kakafika; Moses Elisaf
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study.
Current medical research and opinion 2004;20(11):1691-1701.
2004: Vasilios G Athyros; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Vasilios I Bouloukos; Anthimos N Pehlivanidis; Athanasios N Symeonidis; Moses Elisaf
Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease.
Journal of human hypertension 2004;18(11):781-8.
2004: Haralampos J Milionis; Anna I Kakafika; Sofia G Tsouli; Vasilios G Athyros; Eleni Bairaktari; Konstantinos Seferiadis; Moses S Elisaf
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
American heart journal 2004;148(4):635-40.
2004: Stella S Daskalopoulou; Vasilios G Athyros; Moses Elisaf; Dimitri Mikhailidis
The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
Kidney international 2004;66(4):1714-5.
2004: Triandafillos P Didangelos; A K Thanopoulou; S H Bousboulas; C L Sambanis; Vasilios G Athyros; E A Spanou; K C Dimitriou; S I Pappas; B G Karamanos; Dimitrios T Karamitsos
The ORLIstat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORLICARDIA) Study.
Current medical research and opinion 2004;20(9):1393-401.
2004: Vasilios G Athyros; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Athanasios N Symeonidis; Stella S Daskalopoulou; Anna I Kakafika; Anthimos N Pehlivanidis; Vasilios I Bouloukos; Anatoly Langer
Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
Current medical research and opinion 2004;20(9):1385-92.
2004: Vasilios G Athyros; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Athanasios N Symeonidis; Anthimos N Pehlivanidis; Vasilios I Bouloukos; Moses Elisaf
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.
Journal of clinical pathology 2004;57(7):728-34.
2004: Stella S Daskalopoulou; Vasilios G Athyros; M Elisaf; Dimitri P Mikhailidis
Uric acid levels and vascular disease.
Current medical research and opinion 2004;20(6):951-4.
2004: Vasilios G Athyros; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Athanasios N Symeonidis; Bodosakis R Mercouris; Anthimos N Pehlivanidis; Vasilios I Bouloukos; Moses Elisaf
Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
Current medical research and opinion 2004;20(5):627-37.
2004: Vasilios G Athyros; Moses Elisaf; Athanasios A Papageorgiou; Athanasios N Symeonidis; Anthimos N Pehlivanidis; Vasilios I Bouloukos; Haralambos J Milionis; Dimitri P Mikhailidis
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(4):589-99.
2004: Stella S Daskalopoulou; D P Mikhailidis; Vasilios G Athyros; Athanasios A Papageorgiou; M Elisaf
Fenofibrate and losartan.
Annals of the rheumatic diseases 2004;63(4):469-70.
2003: Vasilios G Athyros; Athanasios A Papageorgiou; Athanasios N Symeonidis; Triandafillos P Didangelos; Anthimos N Pehlivanidis; Vasilios I Bouloukos; Dimitrios P Mikhailidis
Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus.
Angiology 2003;54(6):679-90.
2003: Triandafillos P Didangelos; Georgios A Arsos; Dimitrios T Karamitsos; Vasilios G Athyros; Nikolaos D Karatzas
Left ventricular systolic and diastolic function in normotensive type 1 diabetic patients with or without autonomic neuropathy: a radionuclide ventriculography study.
Diabetes care 2003;26(7):1955-60.
2003: Vasilios G Athyros; Athanasios A Papageorgiou; Athanasios N Symeonidis; Moses Elisaf
Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment.
Atherosclerosis 2003;168(2):397-8.
2003: Vasilios G Athyros; Athanasios A Papageorgiou; Moses Elisaf; Dimitri P Mikhailidis
Statins and renal function in patients with diabetes mellitus.
Current medical research and opinion 2003;19(7):615-7.
2003: Athanasios G Kontopoulos; Vasilios G Athyros; Anthimos N Pehlivanidis; Dimokritos S Demitriadis; Athanasios A Papageorgiou; Harisios Boudoulas
Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients.
Current medical research and opinion 2003;19(1):22-7.
2002: Vasilios G Athyros; Athanasios A Papageorgiou; Valasia V Athyrou; Dimokritos S Demitriadis; Athanasios G Kontopoulos
Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia.
Diabetes care 2002;25(7):1198-202.
2002: Vasilios G Athyros; Athanasios A Papageorgiou; Athanasios G Kontopoulos
Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia.
Atherosclerosis 2002;163(1):205-6.
2002: Vasilios G Athyros; Olga Giouleme; Nikolaos Nikolaidis; Themistoklis V Vasiliadis; Vasilios I Bouloukos; Athanasios G Kontopoulos; Nikolaos Eugenidis
Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis.
Journal of clinical gastroenterology 2002;34(4):472-5.
2002: Vasilios G Athyros; Athanasios A Papageorgiou; Valasia V Athyrou; Dimokritos S Demitriadis; Anthimos N Pehlivanidis; Athanasios G Kontopoulos
Atorvastatin versus four statin-fibrate combinations in patients with familial combined hyperlipidaemia.
Journal of cardiovascular risk 2002;9(1):33-9.
2002: Vasilios G Athyros; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Bodosakis R Mercouris; Valasia V Athyrou; Athanasios N Symeonidis; Elias O Basayannis; Dimokritos S Demitriadis; Athanasios G Kontopoulos
Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
Current medical research and opinion 2002;18(8):499-502.
2002: Vasilios G Athyros; Athanasios A Papageorgiou; Bodosakis R Mercouris; Valasia V Athyrou; Athanasios N Symeonidis; Elias O Basayannis; Dimokritos S Demitriadis; Athanasios G Kontopoulos
Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
Current medical research and opinion 2002;18(4):220-8.
2001: Anthimos N Pehlivanidis; Vasilios G Athyros; Dimokritos S Demitriadis; Athanasios A Papageorgiou; V J Bouloukos; Athanasios G Kontopoulos
Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease.
Atherosclerosis 2001;157(2):463-9.
2001: Vasilios G Athyros; Athanasios A Papageorgiou; Athanasios G Kontopoulos
Statin-fibrate combinations in patients with combined hyperlipedemia.
Atherosclerosis 2001;155(1):263-4.
2001: Vasilios G Athyros; Athanasios A Papageorgiou; Dimokritos S Demitriadis; Athanasios G Kontopoulos
Atorvastatin plus pravastatin for the treatment of heterozygous familial hypercholesterolaemia--a pilot study.
Current medical research and opinion 2001;17(4):267-72.
1999: Athanasios G Kontopoulos; Vasilios G Athyros; Athanasios A Papageorgiou; Harisios Boudoulas
Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction.
The American journal of cardiology 1999;84(10):1164-9.
1998: Dimitrios T Karamitsos; Triandafillos P Didangelos; Vasilios G Athyros; Athanasios G Kontopoulos
The natural history of recently diagnosed autonomic neuropathy over a period of 2 years.
Diabetes research and clinical practice 1998;42(1):55-63.
1998: Triandafillos P Didangelos; Dimitrios T Karamitsos; Vasilios G Athyros; G I Kourtoglou
Effect of aldose reductase inhibition on cardiovascular reflex tests in patients with definite diabetic autonomic neuropathy over a period of 2 years.
Journal of diabetes and its complications 1998;12(4):201-7.
1998: Vasilios G Athyros; Triandafillos P Didangelos; Dimitrios T Karamitsos; Athanasios A Papageorgiou; Harisios Boudoulas; Athanasios G Kontopoulos
Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy.
Acta cardiologica 1998;53(4):201-9.
1997: Vasilios G Athyros; Athanasios A Papageorgiou; H A Hatzikonstandinou; Triandafillos P Didangelos; M V Carina; D F Kranitsas; Athanasios G Kontopoulos
Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia.
The American journal of cardiology 1997;80(5):608-13.
1997: Athanasios G Kontopoulos; Vasilios G Athyros; Athanasios A Papageorgiou; V M Skeberis; E C Basayiannis; Harisios Boudoulas
Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
Coronary artery disease 1997;8(8-9):517-24.
1997: Athanasios G Kontopoulos; Vasilios G Athyros; Triandafillos P Didangelos; Athanasios A Papageorgiou; M J Avramidis; M C Mayroudi; Dimitrios T Karamitsos
Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy.
Diabetes care 1997;20(3):355-61.
1996: Athanasios G Kontopoulos; Vasilios G Athyros; Athanasios A Papageorgiou; H A Hatzikonstandinou; M C Mayroudi; Harisios Boudoulas
Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
Coronary artery disease 1996;7(11):843-50.
1996: Athanasios G Kontopoulos; Vasilios G Athyros; Athanasios A Papageorgiou; G V Papadopoulos; M J Avramidis; Harisios Boudoulas
Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients.
The American journal of cardiology 1996;77(4):242-6.
1996: E D Koutlas; Athanasios A Papageorgiou; Vasilios G Athyros
Holt-Oram syndrome with malformations of renal and cerebral arteries.
Acta cardiologica 1996;51(4):373-6.
1995: Vasilios G Athyros; Athanasios A Papageorgiou; M J Avramidis; Athanasios G Kontopoulos
Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
Coronary artery disease 1995;6(3):251-6.
1994: Athanasios G Kontopoulos; M J Avramides; Vasilios G Athyros
Diagnosis, treatment, and long-term follow up of a patient with a hydatid cyst of the left ventricle.
British heart journal 1994;72(6):592.